FDA approves AbbVie's pivekimab sunirine-PVZY for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare hematologic malignancy

FDA approves AbbVie's pivekimab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories